India, Feb. 24 -- With India's bioeconomy reaching a valuation of $130 billion in 2024, India is working towards bringing a transformative shift towards more sustainable, efficient, and tailored production processes in biomanufacturing. To realise this vision, India has passed the Bio-E3 policy, which puts forth a framework to build bio-enablers in the form of biomanufacturing and bio-Artificial Intelligence (AI) hubs, develop a holistic regulatory environment through intersectoral coordination and focus on skilling and capability development. This brings an inflection point in the biopharma sector, by forging a sustainable pathway for the industry to cater to India's collective aim of a 45% reduction in emission intensity by 2030 and ach...